Woosley RL - Search Results

1

Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility.

Buchert ET, Woosley RL, Swain SM, Oliver SJ, Coughlin SS, Pickle L, Trock B, Riegel AT. Buchert ET, et al. Among authors: woosley rl. Pharmacogenetics. 1993 Dec;3(6):322-7. doi: 10.1097/00008571-199312000-00006. Pharmacogenetics. 1993. PMID: 8148873 No abstract available.

2

The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study.

Balian JD, Sukhova N, Harris JW, Hewett J, Pickle L, Goldstein JA, Woosley RL, Flockhart DA. Balian JD, et al. Among authors: woosley rl. Clin Pharmacol Ther. 1995 Jun;57(6):662-9. doi: 10.1016/0009-9236(95)90229-5. Clin Pharmacol Ther. 1995. PMID: 7781266

3

Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis.

Hou ZY, Chen CP, Yang WC, Lai MD, Buchert ET, Chung HM, Pickle LW, Woosley RL. Hou ZY, et al. Among authors: woosley rl. Clin Pharmacol Ther. 1996 Apr;59(4):411-7. doi: 10.1016/S0009-9236(96)90109-5. Clin Pharmacol Ther. 1996. PMID: 8612385

4

Salivary analysis for determination of dextromethorphan metabolic phenotype.

Hou ZY, Pickle LW, Meyer PS, Woosley RL. Hou ZY, et al. Among authors: woosley rl. Clin Pharmacol Ther. 1991 Apr;49(4):410-9. doi: 10.1038/clpt.1991.48. Clin Pharmacol Ther. 1991. PMID: 2015730

5

Chlorpheniramine plasma concentration and histamine H1-receptor occupancy.

Yasuda SU, Wellstein A, Likhari P, Barbey JT, Woosley RL. Yasuda SU, et al. Among authors: woosley rl. Clin Pharmacol Ther. 1995 Aug;58(2):210-20. doi: 10.1016/0009-9236(95)90199-X. Clin Pharmacol Ther. 1995. PMID: 7648771

6

Pharmacogenetic characteristics of the eosinophilia-myalgia syndrome.

Flockhart DA, Clauw DJ, Sale EB, Hewett J, Woosley RL. Flockhart DA, et al. Among authors: woosley rl. Clin Pharmacol Ther. 1994 Oct;56(4):398-405. doi: 10.1038/clpt.1994.154. Clin Pharmacol Ther. 1994. PMID: 7955801

7

QT interval: a measure of drug action.

Woosley RL, Sale M. Woosley RL, et al. Am J Cardiol. 1993 Aug 26;72(6):36B-43B. doi: 10.1016/0002-9149(93)90039-f. Am J Cardiol. 1993. PMID: 8256753 Free article. Review.

8

d-sotalol reduces heart rate in vivo through a beta-adrenergic receptor-independent mechanism.

Yasuda SU, Barbey JT, Funck-Brentano C, Wellstein A, Woosley RL. Yasuda SU, et al. Among authors: woosley rl. Clin Pharmacol Ther. 1993 Apr;53(4):436-42. doi: 10.1038/clpt.1993.48. Clin Pharmacol Ther. 1993. PMID: 8386603 Clinical Trial.

9

The clinical value of FDA class C drugs approved from 1981 to 1988.

Yasuda SU, Woosley RL. Yasuda SU, et al. Among authors: woosley rl. Clin Pharmacol Ther. 1992 Dec;52(6):577-82. doi: 10.1038/clpt.1992.194. Clin Pharmacol Ther. 1992. PMID: 1458766 No abstract available.

10

The electrocardiographic effects of cetirizine in normal subjects.

Sale ME, Barbey JT, Woosley RL, Edwards D, Yeh J, Thakker K, Chung M. Sale ME, et al. Among authors: woosley rl. Clin Pharmacol Ther. 1994 Sep;56(3):295-301. doi: 10.1038/clpt.1994.140. Clin Pharmacol Ther. 1994. PMID: 7924125 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page